Biotech Stocks Sell-Off After Hitting New Highs Monday
NASDAQ at 4735 off 0.67%
Healthcare and life science stocks have been a safe haven from recent market headwinds but today risk is off across the board. Crude is down over 5% to $61 and this has raised concerns about global growth affecting other asset classes like financials and industrials.The Dow and S&P are […]
SummaryDoing due diligence on a small portion of the mosaic theory related to Inovio and other biotechs led me to doing a small initial study on RedChip.
While RedChip has Inovio listed prominently in multiple areas on its website and has recently Tweeted about it, Inovio is not a client and has never paid RedChip.
Biotech and healthcare stocks listed as RedChip […]
NASDAQ leads -up 0.6% to 4787
The October correction of ~7% was a “headfake” as macro events scared many investor away
Technology and Healthcare Stocks Lead The Way
The healthcare SPDR (XLV) is up 24.5% YTD and the technology SPDR (XLK) is up 18% YTD.
Biotech stocks are at new highs with all major ETFs rallying in November. Our top ETF pick FBT is […]
View gallery.Until the markets pullback a bit, investors and traders will ride this gravy train as long as it goes. Thanks to the market run-up a lot of stocks already seem somewhat extended. However, there are some stocks that are a little late to the party and are just now breaking higher.For example, Celldex Therapeutics, Inc. (NASDAQ: CLDX) just recently broke […]
Please click on the web link below to read the article and watch my videoInternational Business Times Article link (including link to 4-minute Video)Is today’s society addicted to technology? The benefits of the tech we use on a daily basis are plain to see. But with the pervasive influence of social media applications like Facebook, Instagram and Twitter in everyday […]
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]
In part two of the healthcare analytics topic we take a look at the RMADA RFP.It is only through measurement that the quality of healthcare delivered can be improved and its delivery made more efficient. The Federal government can facilitate the highest quality at the lowest cost. Medicare, Medicaid and the Children’s Health Insurance Program (CHIP) all involve the use […]
The Elfenbein Theory Which Explains the Entire Stock MarketI had a little extra time this morning, so I’d thought I’d do a quick post which explains the entire stock market for you.Before I begin, let me stress that I’m discussing generalities of how the stock market behaves. As you read this, I urge you to focus on the larger themes […]
July 2014 Analytics, Big Data, Data Mining Acquisitions and Startups Activity Previous postNext post
July 2014 acquisitions, startups, and company activity in Analytics, Big Data, Data Mining, and Data Science: Twitter buys Madbits, WalmartLabs buys Luvocracy, Zillow buys Trulia, Apple buys Booklamp, Yahoo buys Flurry, Salesforce buys RelateIQ, Couchbase, GE, Databricks, and more. By Gregory Piatetsky, Aug 7, […]
